GIST is the most common mesenchymal tumor of the gastrointestinal tract and can occur throughout this region. It is diagnosed in 10–20 individuals per million annually in the US, and up to 30% ...

Imatinib mesylate targets mutated KIT oncoproteins in gastrointestinal stromal tumor (GIST) and produces a clinical response in 80% of patients. The mechanism is believed to depend predominantly ...

M&S buys main logistics services provider Gist Thu, 21st Jul 2022 10:30 (Sharecast News) - Marks and Spencer has announced the acquisition of its principal contract logistics provider, Gist, from ...

(Sharecast News) - Marks and Spencer has announced the acquisition of its principal contract logistics provider, Gist, from BOG Group, for an initial £145m in cash. The deal is expected to be ...

Cancer is probably the one word no one wants to hear. If you’ve recently been diagnosed with a gastrointestinal stromal tumor (GIST), a relatively rare cancer found in the digestive tract, you ...

The main mechanism of imatinib failure involves the emergence of resistant subpopulations harboring heterogeneous secondary mutations in KIT, which occurs for up to 90% of patients with GIST 26,73 .

Surgery is the main treatment for GISTs that haven’t spread. However, surgery may not be an option for tumors that have spread. GIST tumor surgery.

Their new study, which is published today in Nature Communications, demonstrates that our memories become less vibrant and detailed over time, with only the central gist eventually preserved.